Showing results (11-20 of 231) with videos related to

Sort By:
Pageof 24
CNS Drugs|September 23, 2023
Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World StudiesLuca Prosperini, Shalom Haggiag, Serena Ruggieri, et al.
International Journal of Molecular Sciences|June 12, 2019
Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple SclerosisMarta Corsetti, Gabriella Ruocco, Serena Ruggieri, et al.
Journal of Neurology|September 17, 2021
Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studiesLuca Prosperini, Carla Tortorella, Shalom Haggiag, et al.
Journal of Neurology|January 5, 2022
Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studiesLuca Prosperini, Carla Tortorella, Shalom Haggiag, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 10, 2021
Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple SclerosisLuca Prosperini, Serena Ruggieri, Shalom Haggiag, et al.
Multiple Sclerosis and Related Disorders|May 24, 2025
Brain bright spotty lesions and leukodystrophy-like patterns in NMOSD relapseAlessandro Cruciani, Alessandro Stasolla, Shalom Haggiag, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 28, 2022
Shift of multiple sclerosis onset towards older ageLuca Prosperini, Matteo Lucchini, Serena Ruggieri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 2025
How premorbid structural reserve affects disability accrual in multiple sclerosisElena Barbuti, Luca Prosperini, Serena Ruggieri, et al.
Journal of Neurology|June 29, 2023
The added value of spinal cord lesions to disability accrual in multiple sclerosisSerena Ruggieri, Luca Prosperini, Maria Petracca, et al.
Pageof 24